Biondo Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.9M | Buy |
36,625
+49
| +0.1% | +$17.5K | 1.65% | 24 |
|
|
2025
Q4 | $12M | Buy |
36,576
+78
| +0.2% | +$24.7K | 1.45% | 24 |
|
|
2025
Q3 | $10.3M | Buy |
36,498
+684
| +2% | +$198K | 1.29% | 30 |
|
|
2025
Q2 | $10M | Buy |
35,814
+1,015
| +3% | +$288K | 1.32% | 31 |
|
|
2025
Q1 | $10.8M | Buy |
34,799
+1,482
| +4% | +$438K | 1.54% | 26 |
|
|
2024
Q4 | $8.68M | Buy |
33,317
+735
| +2% | +$218K | 1.2% | 33 |
|
|
2024
Q3 | $10.5M | Buy |
32,582
+327
| +1% | +$107K | 1.44% | 27 |
|
|
2024
Q2 | $10.1M | Buy |
32,255
+912
| +3% | +$268K | 1.49% | 23 |
|
|
2024
Q1 | $8.91M | Buy |
31,343
+215
| +0.7% | +$62.9K | 1.38% | 29 |
|
|
2023
Q4 | $8.97M | Sell |
31,128
-91
| -0.3% | -$24.8K | 1.52% | 23 |
|
|
2023
Q3 | $8.39M | Buy |
31,219
+1,316
| +4% | +$328K | 1.58% | 19 |
|
|
2023
Q2 | $6.64M | Sell |
29,903
-1,955
| -6% | -$454K | 1.23% | 31 |
|
|
2023
Q1 | $7.7M | Buy |
31,858
+2,890
| +10% | +$709K | 1.56% | 27 |
|
|
2022
Q4 | $7.66M | Sell |
28,968
-436
| -1% | -$117K | 1.71% | 24 |
|
|
2022
Q3 | $6.68M | Buy |
29,404
+432
| +1% | +$105K | 1.54% | 28 |
|
|
2022
Q2 | $7.1M | Buy |
28,972
+1,260
| +5% | +$309K | 1.56% | 27 |
|
|
2022
Q1 | $6.75M | Buy |
27,712
+1,615
| +6% | +$371K | 1.19% | 33 |
|
|
2021
Q4 | $5.92M | Buy |
26,097
+1,195
| +5% | +$252K | 0.99% | 39 |
|
|
2021
Q3 | $5.34M | Buy |
24,902
+860
| +4% | +$198K | 0.92% | 39 |
|
|
2021
Q2 | $5.9M | Buy |
24,042
+1,105
| +5% | +$272K | 1.01% | 39 |
|
|
2021
Q1 | $5.75M | Buy |
22,937
+656
| +3% | +$157K | 1.14% | 35 |
|
|
2020
Q4 | $5.16M | Buy |
22,281
+5
| +0% | +$1.15K | 0.99% | 37 |
|
|
2020
Q3 | $5.7M | Buy |
22,276
+559
| +3% | +$138K | 1.24% | 28 |
|
|
2020
Q2 | $5.13M | Buy |
21,717
+16,150
| +290% | +$3.68M | 1.3% | 26 |
|
|
2020
Q1 | $1.14M | Sell |
5,567
-37
| -0.7% | -$8.08K | 0.38% | 40 |
|
|
2019
Q4 | $1.36M | Sell |
5,604
-5
| -0.1% | -$1.1K | 0.31% | 47 |
|
|
2019
Q3 | $1.09M | Buy |
5,609
+24
| +0.4% | +$4.61K | 0.28% | 50 |
|
|
2019
Q2 | $1.04M | Sell |
5,585
-5
| -0.1% | -$895 | 0.25% | 51 |
|
|
2019
Q1 | $1.07M | Sell |
5,590
-20
| -0.4% | -$3.82K | 0.27% | 48 |
|
|
2018
Q4 | $1.1M | Sell |
5,610
-45
| -0.8% | -$8.78K | 0.33% | 45 |
|
|
2018
Q3 | $1.18M | Sell |
5,655
-145
| -3% | -$28.6K | 0.28% | 46 |
|
|
2018
Q2 | $1.08M | Hold |
5,800
| – | – | 0.27% | 49 |
|
|
2018
Q1 | $996K | Hold |
5,800
| – | – | 0.26% | 56 |
|
|
2017
Q4 | $1.01M | Sell |
5,800
-275
| -5% | -$48.7K | 0.26% | 57 |
|
|
2017
Q3 | $1.14M | Sell |
6,075
-6,085
| -50% | -$1.08M | 0.31% | 52 |
|
|
2017
Q2 | $2.11M | Buy |
12,160
+5,980
| +97% | +$973K | 0.61% | 45 |
|
|
2017
Q1 | $946K | Buy |
6,180
+50
| +0.8% | +$8.31K | 0.34% | 50 |
|
|
2016
Q4 | $896K | Sell |
6,130
-134
| -2% | -$20.2K | 0.3% | 51 |
|
|
2016
Q3 | $1.04M | Buy |
6,264
+84
| +1% | +$14.2K | 0.35% | 51 |
|
|
2016
Q2 | $940K | Sell |
6,180
-500
| -7% | -$77.7K | 0.34% | 50 |
|
|
2016
Q1 | $1M | Sell |
6,680
-1,775
| -21% | -$264K | 0.38% | 49 |
|
|
2015
Q4 | $1.37M | Sell |
8,455
-400
| -5% | -$62.9K | 0.46% | 48 |
|
|
2015
Q3 | $1.23M | Sell |
8,855
-6,750
| -43% | -$1.06M | 0.41% | 50 |
|
|
2015
Q2 | $2.4M | Hold |
15,605
| – | – | 0.72% | 37 |
|
|
2015
Q1 | $2.49M | Sell |
15,605
-250
| -2% | -$39.4K | 0.74% | 35 |
|
|
2014
Q4 | $2.53M | Hold |
15,855
| – | – | 0.76% | 33 |
|
|
2014
Q3 | $2.23M | Sell |
15,855
-100
| -0.6% | -$13.1K | 0.68% | 38 |
|
|
2014
Q2 | $1.89M | Sell |
15,955
-300
| -2% | -$34.7K | 0.6% | 38 |
|
|
2014
Q1 | $2M | Sell |
16,255
-1,860
| -10% | -$226K | 0.66% | 37 |
|
|
2013
Q4 | $2.07M | Sell |
18,115
-400
| -2% | -$45.5K | 0.71% | 33 |
|
|
2013
Q3 | $2.07M | Sell |
18,515
-1,450
| -7% | -$157K | 0.79% | 26 |
|
|
2013
Q2 | $1.97M | Buy |
+19,965
| New | +$2.07M | 0.85% | 21 |
|
Other funds holding AMGN
VCM
VPM
Biondo Investment Advisors's AMGN Position: Q1 2026 in Review
Biondo Investment Advisors increased its Amgen (AMGN) stake by 0.13% in Q1 2026, buying an estimated $17.5K and bringing the position to 36,625 shares worth $12.9M. The position accounts for 1.65% of the portfolio, ranked #24.
Biondo Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Biondo Investment Advisors held 36,625 shares of Amgen worth $12.9M as of Q1 2026.
- Biondo Investment Advisors bought 49 Amgen shares in Q1 2026, an estimated $17.5K.
- Amgen made up 1.65% of Biondo Investment Advisors's portfolio in Q1 2026, its #24 holding.
- Biondo Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.